DELIA DAGLI: Open Payments
NPI 1720315682 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,925 in 125 payments from 17 companies in 2025. Trend: 2023 $1,643 · 2024 $2,415 · 2025 $2,925
Food & beverage: $2,813Education: $112
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $501 |
| Janssen Biotech, Inc. | 10 | $382 |
| GENZYME CORPORATION | 8 | $288 |
| ABBVIE INC. | 22 | $283 |
| Amgen Inc. | 8 | $238 |
| Galderma Laboratories, L.P. | 19 | $236 |
| LEO Pharma Inc. | 11 | $192 |
| Regeneron Healthcare Solutions, Inc. | 8 | $176 |
| E.R. Squibb & Sons, L.L.C. | 7 | $138 |
| Lilly USA, LLC | 5 | $119 |
Products named: Bimzelx, TREMFYA, DUPIXENT, OTEZLA, NEMLUVIO, SKYRIZI, Sotyktu, RINVOQ.
Industry payments across MA — which companies pay providers there.
